-
PAREXEL, Vanderbilt University, Boehringer Ingelheim, And More: News From March 2018
Bio-IT World | March featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including PAREXEL, Vanderbilt University, Boehringer Ingelheim, and more.
Mar 28, 2018
-
CRISPR Restored: Scientists Reverse Finding That Gene Editing Technology Had Flaws
Forbes | Last summer a paper appeared suggesting that CRISPR gene editing could cause hundreds of off-target mutations. Turns out that was wrong, and the authors have just published a preprint admitting it.
Mar 27, 2018
-
Sequencing Patients' Genomes Might Not Break The Health Care Bank
STAT | The first rigorous study of its kind finds that sequencing people's genomes might not lead to extensive and expensive follow-up care, researchers reported.
Mar 22, 2018
-
CRISPR Strategy & Standards: How Synthego’s Free Software Lays The Groundwork For CRISPR Futures
Bio-IT World | Synthego has had a remarkable year of development, including their Inference of CRISPR Edits, an open source algorithm for validating CRISPR edits that offers rapid, reproducible analysis of Sanger sequencing data.
Mar 21, 2018
-
Global Gene Corp, Regeneron Announce Largest Genomics Program For Indian Population
The Times of India | Global Gene Corp, a well-known genomics data platform, has teamed up with US-based Regeneron Genetics Center (RGC) to sequence the exomes of people from the Indian subcontinent and examine the links between human genetic variations and specific diseases.
Mar 20, 2018
-
The Struggle To Build A Massive “Biobank” Of Patient Data
The New York Times | At a cost of $1.4 billion, the NIH’s All of Us program may help scientists discover new links between diseases, genes, and lifestyle. But the project faces formidable obstacles.
Mar 19, 2018
